Bormioli Pharma returns to DCAT Week in New York, 21 to 24 March, introducing on the American market a truly renewed company.

The company never stopped investing, enhancing its commercial presence in the US with an on-site team and a warehouse to serve every industry need nationwide.

Hosted by the Drug, Chemical & Associated Technologies Association (DCAT) the event is not a trade show, it is a multifaceted event where Member Companies have the opportunity to reserve meeting space to conduct high-level, private, strategic meetings with customers and suppliers.

Bormioli will present a renewed ForTherapy portfolio composed of Type I and tubing glass containers and vials, aluminium seals and rubber stoppers, together with scientific counsel provided to clients all along the process.

"Industry forecasts indicate that the parenteral drug segment will grow at a CAGR of +5.6% over the period 2020-2026 in the North American pharma market” commented Andrea Lodetti, CEO of Bormioli Pharma. “We are the only supplier that can provide the complete primary packaging solution and we have lead time capabilities that allow us to be agile and respond to the increasing saturation of the market. DCAT Week is an excellent opportunity to consolidate existing partnerships and generate new business opportunities".

The company also promptly addresses sustainability concerns, with several product ranges and accessories manufactured in recycled plastics and in bio-based plastic solutions, together with endlessly recyclable glass solutions.

All these solutions feature maximum quality, efficiency and aesthetics.

www.bormiolipharma.com

Image: Bormioli Pharma will be in New York at the DCAT gathering.